Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis
Urologic Oncology: Seminars and Original Investigations | Apr 21, 2018
Monopolar vs bipolar transurethral resection for non–muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial
Urologic Oncology: Seminars and Original Investigations | Apr 20, 2018
Most read this week